Disha Patil

AdvaGen Pharma is an integrated specialty pharmaceutical company, focused on providing innovative solutions for patients, customers, and partners by developing, manufacturing, and marketing high quality prescription branded and generic pharmaceutical products. It is poised for growth by introducing value-added pharmaceuticals across the oral solids, oral liquids, topicals, injectables, and nasal spray dosage forms, as well as niche, high barrier opportunities across medical devices and drug-device combinations. AdvaGen Pharma sources its products from its parent organization, Rubicon Research Pvt Ltd, as well as from a network of high quality, US FDA inspected manufacturing facilities across the globe. AdvaGen’s strong focus on reliable supplies is backed by own manufacturing across oral solid and liquid products and upcoming expansion of sites to also include complex dosage forms like sterile and drug device products. AdvaGen will continue to source over 70% of its products by in-house manufacturing through its rapid expansion portfolio expansion. The name AdvaGen is a combination of the words ‘ADVAnced GENerics’ and we believe that we are firmly on our way to establishing our mission through our rapidly expanding product portfolio, innovations that fulfil unmet medical needs, and by enabling smarter health care delivery.